Los Altos Hills, CA, United States of America

George Frederic Schreiner

This inventor holds 35 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent, primarily in Pharmaceutical Compounds. Top assignees: Scios Inc., Cv Therapeutics, Inc., Epirium Bio Inc.. Active years: 1997-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: George Frederic Schreiner. Retrieved from https://idiyas.com/inventor/george-frederic-schreiner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 35 

% Patents Active = 88.6


Average Co-Inventor Count = 3.4

ph-index = 13

Forward Citations = 698(Granted Patents)


Location History:

  • Los Altos, CA (US) (1997 - 2008)
  • Sunnyvale, CA (US) (2015 - 2018)
  • Los Altos Hills, CA (US) (1998 - 2023)

Company Filing History:


Years Active: 1997-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
Hydroxysteroid Compounds
Flavonoid Compounds
Pyrido-Pyrimidine Compounds
Quinazoline Derivatives
Cardiac Failure Treatments
Mitochondrial Toxicity
Muscular Disorders
Eclampsia Treatment
p38-a Kinase Inhibitors
Gene Detection Methods
Hypertension Treatments
35 patents (USPTO):Explore Patents

Title: George Frederic Schreiner - Innovator in Biopharmaceuticals

Introduction

George Frederic Schreiner, based in Los Altos Hills, California, is a prominent inventor known for his significant contributions to the biopharmaceutical field, with a remarkable portfolio that includes 35 patents. His work has focused on innovative solutions for treating muscular and bone disorders through novel steroidal compounds.

Latest Patents

Among his latest inventions, schreiner has developed hydroxysteroid compounds, their intermediates, processes for preparation, and compositions that underline the significance of these novel steroidal compounds. Furthermore, he has created compounds and compositions specifically designed for the treatment of muscular disorders and bone diseases. These inventions highlight a comprehensive approach to addressing injuries and impairments in both skeletal and cardiac muscles, offering promising applications in pharmaceuticals aimed at improving muscle function and overall health in humans and animals.

Career Highlights

Schreiner has held key positions in leading companies within the biopharmaceutical industry. He has notably worked for Scios Inc. and Cv Therapeutics, Inc., where he further honed his skills and contributed to advanced research in drug development and therapeutic solutions.

Collaborations

Throughout his career, Schreiner has collaborated with esteemed professionals, including John A. Lewicki and David Y. Liu. These partnerships have enhanced his work and contributed to the successful development of innovative pharmaceutical substances.

Conclusion

George Frederic Schreiner stands out as a dedicated inventor whose work has the potential to make significant strides in medical treatments for muscular and bone disorders. His extensive patent portfolio underscores his commitment to innovation, making him a key player in the field of biopharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…